Atara Biotherapeutics's market cap is currently $43.31M. The company's EPS TTM is $-25.657; its P/E ratio is ―; Atara Biotherapeutics is scheduled to report earnings on March 3, 2025, and the estimated EPS forecast is $-2.76. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 8.57M	$ 63.57M	$ 20.34M	$ 0.00	$ 0.00
Gross Profit	$ -313.00K	$ 49.01M	$ 8.96M	$ -9.87M	$ -8.11M
Operating Income	$ -276.01M	$ -280.51M	$ -340.46M	$ -309.05M	$ -295.68M
EBITDA	$ -266.00M	$ -213.72M	$ -331.12M	$ -296.74M	$ -282.86M
Net Income	$ -276.13M	$ -2.28B	$ -3.40B	$ -3.07B	$ -2.91B
Balance Sheet
Cash & Short-Term Investments	$ 51.73M	$ 242.82M	$ 371.07M	$ 500.66M	$ 259.11M
Total Assets	$ 165.50M	$ 376.42M	$ 468.13M	$ 588.12M	$ 342.94M
Total Debt	$ 57.87M	$ 71.70M	$ 25.52M	$ 13.04M	$ 14.14M
Net Debt	$ 32.03M	$ -21.24M	$ -80.57M	$ -187.36M	$ -60.18M
Total Liabilities	$ 264.74M	$ 249.78M	$ 188.51M	$ 125.78M	$ 52.16M
Stockholders' Equity	$ -99.23M	$ 126.64M	$ 279.61M	$ 462.34M	$ 290.78M
Cash Flow
Free Cash Flow	$ -194.20M	$ -274.62M	$ -231.10M	$ -185.27M	$ -241.36M
Operating Cash Flow	$ -192.98M	$ -270.43M	$ -220.52M	$ -180.76M	$ -235.63M
Investing Cash Flow	$ 123.87M	$ 202.96M	$ 22.26M	$ -120.73M	$ 60.46M
Financing Cash Flow	$ 2.01M	$ 53.08M	$ 103.94M	$ 427.57M	$ 188.79M

Currency in USD

Atara Biotherapeutics Earnings and Revenue History

Income Statement >

Atara Biotherapeutics Debt to Assets

Balance Sheet >

Atara Biotherapeutics Cash Flow

Cash Flow >

Atara Biotherapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing